United States Solid Tumors Drugs Market Report 2016

Publisher Name :
Date: 15-Sep-2016
No. of pages: 116
Inquire Before Buying

Notes:

Sales, means the sales volume of Solid Tumors Drugs

Revenue, means the sales value of Solid Tumors Drugs

This report studies sales (consumption) of Solid Tumors Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Hoffmann-La Roche

- Novartis

- Celgene

- Johnson & Johnson

- Pfizer

- BMS

- AbbVie

- AbGenomics

- ADC Therapeutics

- TG Therapeutics

- Polaris Pharmaceuticals

- Immunogen

- CTI BioPharma

- Chugai Pharmaceutical

- NewLink Genetics

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Solid Tumors Drugs in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Solid Tumors Drugs Market Report 2016

Table of Contents
United States Solid Tumors Drugs Market Report 2016
1 Solid Tumors Drugs Overview
1.1 Product Overview and Scope of Solid Tumors Drugs
1.2 Classification of Solid Tumors Drugs
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Solid Tumors Drugs
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Solid Tumors Drugs (2011-2021)
1.4.1 United States Solid Tumors Drugs Sales and Growth Rate (2011-2021)
1.4.2 United States Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
2 United States Solid Tumors Drugs Competition by Manufacturers
2.1 United States Solid Tumors Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Solid Tumors Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Solid Tumors Drugs Average Price by Manufactures (2015 and 2016)
2.4 Solid Tumors Drugs Market Competitive Situation and Trends
2.4.1 Solid Tumors Drugs Market Concentration Rate
2.4.2 Solid Tumors Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Solid Tumors Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Solid Tumors Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Solid Tumors Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Solid Tumors Drugs Price by Type (2011-2016)
3.4 United States Solid Tumors Drugs Sales Growth Rate by Type (2011-2016)
4 United States Solid Tumors Drugs Sales (Volume) by Application (2011-2016)
4.1 United States Solid Tumors Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Solid Tumors Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Solid Tumors Drugs Manufacturers Profiles/Analysis
5.1 Hoffmann-La Roche
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Solid Tumors Drugs Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Hoffmann-La Roche Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Novartis
5.2.2 Solid Tumors Drugs Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Novartis Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Celgene
5.3.2 Solid Tumors Drugs Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Celgene Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Johnson & Johnson
5.4.2 Solid Tumors Drugs Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Johnson & Johnson Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Pfizer
5.5.2 Solid Tumors Drugs Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Pfizer Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 BMS
5.6.2 Solid Tumors Drugs Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 BMS Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 AbbVie
5.7.2 Solid Tumors Drugs Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 AbbVie Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 AbGenomics
5.8.2 Solid Tumors Drugs Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 AbGenomics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 ADC Therapeutics
5.9.2 Solid Tumors Drugs Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 ADC Therapeutics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 TG Therapeutics
5.10.2 Solid Tumors Drugs Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 TG Therapeutics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Polaris Pharmaceuticals
5.12 Immunogen
5.13 CTI BioPharma
5.14 Chugai Pharmaceutical
5.15 NewLink Genetics
6 Solid Tumors Drugs Manufacturing Cost Analysis
6.1 Solid Tumors Drugs Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Solid Tumors Drugs
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Solid Tumors Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Solid Tumors Drugs Market Forecast (2016-2021)
10.1 United States Solid Tumors Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Solid Tumors Drugs Sales Forecast by Type (2016-2021)
10.3 United States Solid Tumors Drugs Sales Forecast by Application (2016-2021)
10.4 Solid Tumors Drugs Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Solid Tumors Drugs
Table Classification of Solid Tumors Drugs
Figure United States Sales Market Share of Solid Tumors Drugs by Type in 2015
Table Application of Solid Tumors Drugs
Figure United States Sales Market Share of Solid Tumors Drugs by Application in 2015
Figure United States Solid Tumors Drugs Sales and Growth Rate (2011-2021)
Figure United States Solid Tumors Drugs Revenue and Growth Rate (2011-2021)
Table United States Solid Tumors Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Solid Tumors Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Solid Tumors Drugs Sales Share by Manufacturers
Figure 2016 Solid Tumors Drugs Sales Share by Manufacturers
Table United States Solid Tumors Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Solid Tumors Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Solid Tumors Drugs Revenue Share by Manufacturers
Table 2016 United States Solid Tumors Drugs Revenue Share by Manufacturers
Table United States Market Solid Tumors Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Solid Tumors Drugs Average Price of Key Manufacturers in 2015
Figure Solid Tumors Drugs Market Share of Top 3 Manufacturers
Figure Solid Tumors Drugs Market Share of Top 5 Manufacturers
Table United States Solid Tumors Drugs Sales by Type (2011-2016)
Table United States Solid Tumors Drugs Sales Share by Type (2011-2016)
Figure United States Solid Tumors Drugs Sales Market Share by Type in 2015
Table United States Solid Tumors Drugs Revenue and Market Share by Type (2011-2016)
Table United States Solid Tumors Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Solid Tumors Drugs by Type (2011-2016)
Table United States Solid Tumors Drugs Price by Type (2011-2016)
Figure United States Solid Tumors Drugs Sales Growth Rate by Type (2011-2016)
Table United States Solid Tumors Drugs Sales by Application (2011-2016)
Table United States Solid Tumors Drugs Sales Market Share by Application (2011-2016)
Figure United States Solid Tumors Drugs Sales Market Share by Application in 2015
Table United States Solid Tumors Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Solid Tumors Drugs Sales Growth Rate by Application (2011-2016)
Table Hoffmann-La Roche Basic Information List
Table Hoffmann-La Roche Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Hoffmann-La Roche Solid Tumors Drugs Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Solid Tumors Drugs Sales Market Share (2011-2016)
Table Celgene Basic Information List
Table Celgene Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celgene Solid Tumors Drugs Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Solid Tumors Drugs Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Solid Tumors Drugs Sales Market Share (2011-2016)
Table BMS Basic Information List
Table BMS Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table BMS Solid Tumors Drugs Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Solid Tumors Drugs Sales Market Share (2011-2016)
Table AbGenomics Basic Information List
Table AbGenomics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbGenomics Solid Tumors Drugs Sales Market Share (2011-2016)
Table ADC Therapeutics Basic Information List
Table ADC Therapeutics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table ADC Therapeutics Solid Tumors Drugs Sales Market Share (2011-2016)
Table TG Therapeutics Basic Information List
Table TG Therapeutics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table TG Therapeutics Solid Tumors Drugs Sales Market Share (2011-2016)
Table Polaris Pharmaceuticals Basic Information List
Table Polaris Pharmaceuticals Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Polaris Pharmaceuticals Solid Tumors Drugs Sales Market Share (2011-2016)
Table Immunogen Basic Information List
Table Immunogen Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Immunogen Solid Tumors Drugs Sales Market Share (2011-2016)
Table CTI BioPharma Basic Information List
Table CTI BioPharma Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table CTI BioPharma Solid Tumors Drugs Sales Market Share (2011-2016)
Table Chugai Pharmaceutical Basic Information List
Table Chugai Pharmaceutical Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chugai Pharmaceutical Solid Tumors Drugs Sales Market Share (2011-2016)
Table NewLink Genetics Basic Information List
Table NewLink Genetics Solid Tumors Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table NewLink Genetics Solid Tumors Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Solid Tumors Drugs
Figure Manufacturing Process Analysis of Solid Tumors Drugs
Figure Solid Tumors Drugs Industrial Chain Analysis
Table Raw Materials Sources of Solid Tumors Drugs Major Manufacturers in 2015
Table Major Buyers of Solid Tumors Drugs
Table Distributors/Traders List
Figure United States Solid Tumors Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Solid Tumors Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Solid Tumors Drugs Production Forecast by Type (2016-2021)
Table United States Solid Tumors Drugs Consumption Forecast by Application (2016-2021)
  • 2018-2023 Global PEGylated Proteins Consumption Market Report
    Published: 15-Jun-2018        Price: US 4660 Onwards        Pages: 138
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global PEGylated Proteins market for 2018-2023. PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s. The threat of substitutes arises when there a......
  • 2018 Top 5 PEGylated Proteins Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 15-Jun-2018        Price: US 4960 Onwards        Pages: 125
    PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s. The threat of substitutes arises when there are similar products developed by competitors which satisfy the market needs. When consumers have access to substitute products which can satisfy their market needs, then manufacturer......
  • 2018-2023 Global Erythropoietin Consumption Market Report
    Published: 15-Jun-2018        Price: US 4660 Onwards        Pages: 131
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Erythropoietin market for 2018-2023. Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adult......
  • 2018 Top 5 Erythropoietin Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 15-Jun-2018        Price: US 4960 Onwards        Pages: 125
    Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood. Erythropoietin is an essential hormone for red blood cell production. Without it, definitive erythropoiesis does not take place. Under hypoxic conditions, t......
  • Global Enzymatic Debridement Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Jun-2018        Price: US 3480 Onwards        Pages: 129
    Enzymatic Debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue - if the enzymes come in contact with healthy tissue, they could cause issues. Scope of the Report: This report focuses on the Enzymatic Debridement in global market, especially in North America, Europe and Asia-Pacific, South Ame......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Enzymatic Debridement Market 2018, Forecast to 2023
    Published: 15-Jun-2018        Price: US 4880 Onwards        Pages: 133
    Enzymatic Debridement uses chemical enzymes to assist in wound healing. Enzymes that help slough off the dead tissue are often available as part of a topic ointment; however, the ointment must be carefully applied to only the currently dead tissue - if the enzymes come in contact with healthy tissue, they could cause issues. Scope of the Report: This report focuses on the Enzymatic Debridement in global market, especially in North America, Europe and Asia-Pacific, South Ame......
  • Global Vaccine Market, People Vaccinated, Administered, Immunization, By Disease, By End User, Companies
    Published: 14-Jun-2018        Price: US 1990 Onwards        Pages: 355
    Global Vaccine Market is projected to reach US$ 70 Billion by the year 2024. The vaccine market is likely to witness a significant growth throughout the forecast period due to the growing prevalence of diseases, increasing government and non-government funding for vaccine development & distribution and increasing investments by companies to develop new vaccines. Furthermore, growing demand for preventive vaccines, rising consciousness about vaccination coupled with mounting demand from th......
  • Global Celery Seed Extract Solid Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 13-Jun-2018        Price: US 3480 Onwards        Pages: 135
    Celery seed solid extract and oil are majorly used for healthcare benefits as anti-spasmodic, nerve stimulant, stimulant and tonic in asthma, rheumatoid arthritis, intestinal antiseptic. The essential oil of celery seed comprise of sesquiterpene alcohols, sedanolide, d-limonene, selinene, and sedanonic anhydride. Celery oil is mostly used for flavoring of food and perfumes. Scope of the Report: This report focuses on the Celery Seed Extract Solid in global market, especial......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Celery Seed Extract Solid Market 2018, Forecast to 2023
    Published: 13-Jun-2018        Price: US 4880 Onwards        Pages: 128
    Celery seed solid extract and oil are majorly used for healthcare benefits as anti-spasmodic, nerve stimulant, stimulant and tonic in asthma, rheumatoid arthritis, intestinal antiseptic. The essential oil of celery seed comprise of sesquiterpene alcohols, sedanolide, d-limonene, selinene, and sedanonic anhydride. Celery oil is mostly used for flavoring of food and perfumes. Scope of the Report: This report focuses on the Celery Seed Extract Solid in global market, especial......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs